|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed显示文摘 | Keating MJ Cazin B Coutr6 S | 2002 | J Clin Oncol2002，20，1： | 1 |
| 2 | Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia 显示文摘 | Tournilhac O Cazin B Lepr6tre S | 2004 | Blood2004，103，1： | 1 |
| 3 | Use of infrared thermography for the study of evaporation in a square capillary tube显示文摘 | Chauvet F Cazin S Duru P | 2010 | International Journal of Heat and Mass Transfer2010，53，910： | 1 |
| 4 | nephron sparing surgery for renal cell carcinoma using selective renal parenchymal clamping显示文摘 | vogt B cazin S | 2002 | jurol2002，167，1： | 1 |
| 5 | Randomized comparison of fludarahine,CAP, and CHOP in 938 previously untreated stage B and C chronic lymphocytic Ieukemia patients 显示文摘 | Leporrier M Chevret S Cazin B | 2001 | Blood2001，98，8： | 1 |
| 6 | The development of palladium catalysts for C-C and C-heteroatom bond forming reactions of aryl chloride substrates显示文摘 | Bedford R B Cazin C S J Holder D | 2004 | Coordination chemistry reviews2004，248，21： | 1 |
| 7 | Randomized com- parison of fludarabine, CAP and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients 显示文摘 | Leporrier M Chevret S Cazin B | 2001 | Blood2001，98，8： | 1 |
| 8 | Randomized comparison of fludarabine,CAP,and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients显示文摘 | Leporrier M Cheet S Cazin B | 2001 | {H}Blood2001，，08： | 1 |
| 9 | Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients 显示文摘 | Leporrier M Chevret S Cazin B | 2001 | Blood2001，98，8： | 1 |
| 10 | Silica-supported imine palladacycles recyclable catalysts for the Suzuki reaction 显示文摘 | Bedford Robin B Cazin Catherine S J Hursthouse Michael B | 2001 | Journal of Organometallie Chemistry2001，633，12： | 1 |
| 11 | Silicasupported imine palladacycles-recyclable catalysts for the Suzuki reaction 显示文摘 | BEDFORD R B CAZIN C S J HURSTHOUSE M B | 2001 | Journal of Organometallic Chemistry2001，633，： | 1 |
| 12 | Randomized comparison of fludarabine, CAP,and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients显示文摘 | Leporrier M Chevret S Cazin B | 2001 | Blood2001，98，： | 1 |
| 13 | High-activity catalysts for Suzuki coupling and amination reactions with deactivated aryl chloride substrates: importance of the palladium source 显示文摘 | Bedford R B Cazin C S J Coles S J | 2003 | Organometallics2003，22，5： | 1 |
| 14 | Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B - cell chronic lymphocytic leukemia 显示文摘 | Tournilhac O Cazin B Lepretre S | 2004 | Blood2004，103，1： | 1 |
| 15 | Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B - cell chronic lymphocytic leukemia显示文摘 | Tournilhac O Cazin B Lepretre S | 2004 | Blood2004，103，1： | 1 |
| 16 | Randomized comparison of fludarabine,CAP, and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients显示文摘 | Leporier M Chevret S Cazin B | 2001 | Blood2001，98，8： | 1 |
| 17 | Randomized comparison of fludarabine, CAP and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients 显示文摘 | Leporrier M Chevert S Cazin B | 2001 | Blood2001，98，8： | 1 |
| 18 | Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed显示文摘 | Keating MJ Cazin B Coutre S | 2002 | J Clin Oncol2002，20，1： | 1 |
| 19 | Nephron sparing surgery for renal cell carcinoma using selective renal parenchymal clamping显示文摘 | Menean a vog b cazin S | 2002 | Urol2002，168，1： | 1 |
| 20 | Nephron sparing surgery for renal cell carcinoma using selective renal parenchymal clamping 显示文摘 | Menean A Vogt B Cazin S | 2002 | J Urol2002，168，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员